深度学习用于高分辨率剂量预测,用于乳腺癌治疗的高剂量速率支臂疗法
Sébastien Quetin1,2, Boris Bahoric3, Farhad Maleki4,5,6
1Medical Physics Unit, Department of Oncology, McGill University, Montreal, QC, Canada.
Physics in medicine and biology
|April 11, 2024
概括
这项研究引入了一种新的深度学习方法,用于更快,更准确的辐射疗法剂量计算,用于高剂量速率支臂疗法. 该方法在显著减少的计算时间内实现蒙特卡洛模拟精度,从而实现临床集成.
科学领域:
- 医学物理 医学物理
- 辐射疗法 辐射疗法
- 计算剂量计计算剂量计.
背景情况:
- 蒙特卡洛 (MC) 模拟是精确放射治疗剂量计算的黄金标准,特别是在特定患者的高剂量速率胸膜疗法 (HDR BT) 中,组织异质性至关重要.
- 由于MC模拟的大量计算时间,这阻碍了它们的广泛临床应用.
- 以前的深度学习 (DL) 模型实现了MC级准确度,但由于GPU限制,它们仅限于较低的分辨率 (3mm × 3mm × 3mm voxels).
研究的目的:
- 开发一种基于DL的剂量预测方法,在高分辨率 (1mm × 1mm × 1mm voxels) 上具有MC模拟精度.
- 为了在临床上可接受的时间框架内实现这些预测.
- 为了使精确的剂量计算,考虑到患者特定的组织组成.
主要方法:
- 使用了98名乳腺癌患者的CT扫描,这些患者接受了Iridium-192 HDR BT治疗 (培训70人,验证14人,测试14人).
- 开发了一种基于种子距离的新型作物策略,以减少数据量,以在1毫米分辨率下高效地训练3D DL模型.
- 提出了一种新的DL架构,具有层级融合,通过将TG-43剂量与水中的水 (D_w) 整合到患者组织组成数据来预测剂量到中等-在-中等 (D_m).
主要成果:
- 拟议的DL方法实现了最先进的性能,与MC D_m地图匹配,但运行速度快300倍.
- 关键剂量计指数的证明最小平均绝对百分比误差:PTV V100的0.17% ± 0.15%,皮肤D2的0.30% ± 0.32%,肺D2的0.82% ± 0.79%,胸壁D2的0.34% ± 0.29%,心脏D2的1.08% ± 0.98%.
- 该方法成功地将TG-43 D_w地图转换为高分辨率的D_m地图.
结论:
- 新的DL策略使TG-43剂量分布能够高效准确地转换为高分辨率,中等特异性的剂量分布.
- 这种方法克服了MC模拟的计算局限性,为HDR BT.提供了临床上可行的替代方案.
- 提出的方法的高准确性和速度使其更容易融入临床工作流程,以改善放射治疗规划.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.8K
相关概念视频
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394
Therapeutic Drug Monitoring: Drug Analysis Methods
342
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342
